Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boghen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Clinical Pharmacology|January 1, 1985
Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulationC Ferrari, P Rampini, A Paracchi, et al.
Pharmaceutical Research|August 1, 1997
Hepatic extraction of hexarelin, a new peptidic GH secretagogue, in the isolated perfused rat liverM Roumi, S Marleau, M Boghen, et al.
Journal of Endocrinological Investigation|February 1, 1983
Serum free thyroid hormones in T3-toxicosis: a study of 35 patientsC Ferrari, M Romussi, P Rampini, et al.
Clinical Pharmacology and Therapeutics|July 1, 1983
Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjectsC Ferrari, C Barbieri, R Caldara, et al.
Acta Endocrinologica|April 1, 1987
Serum free thyroid hormones in different degrees of hypothyroidism and in euthyroid autoimmune thyroiditisC Ferrari, A Paracchi, E Parisio, et al.
Clinical Endocrinology|November 1, 1988
Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patientsC Ferrari, A Paracchi, C Romano, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1986
Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patientsC Ferrari, C Barbieri, R Caldara, et al.
Human Reproduction (Oxford, England)|April 1, 1990
Pregnancy following combined growth hormone--pulsatile GnRH treatment in a patient with hypothalamic amenorrhoeaA Volpe, G Coukos, P G Artini, et al.
Clinical Endocrinology|August 1, 1990
The effect of galanin on baseline and GHRH-induced growth hormone secretion in obese childrenS Loche, S Pintus, S G Cella, et al.
Endocrinology|January 8, 1998
Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labelingH Ong, N McNicoll, E Escher, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Clinical Pharmacology|January 1, 1985
Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulationC Ferrari, P Rampini, A Paracchi, et al.
Pharmaceutical Research|August 1, 1997
Hepatic extraction of hexarelin, a new peptidic GH secretagogue, in the isolated perfused rat liverM Roumi, S Marleau, M Boghen, et al.
Journal of Endocrinological Investigation|February 1, 1983
Serum free thyroid hormones in T3-toxicosis: a study of 35 patientsC Ferrari, M Romussi, P Rampini, et al.
Clinical Pharmacology and Therapeutics|July 1, 1983
Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjectsC Ferrari, C Barbieri, R Caldara, et al.
Acta Endocrinologica|April 1, 1987
Serum free thyroid hormones in different degrees of hypothyroidism and in euthyroid autoimmune thyroiditisC Ferrari, A Paracchi, E Parisio, et al.
Clinical Endocrinology|November 1, 1988
Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patientsC Ferrari, A Paracchi, C Romano, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1986
Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patientsC Ferrari, C Barbieri, R Caldara, et al.
Human Reproduction (Oxford, England)|April 1, 1990
Pregnancy following combined growth hormone--pulsatile GnRH treatment in a patient with hypothalamic amenorrhoeaA Volpe, G Coukos, P G Artini, et al.
Clinical Endocrinology|August 1, 1990
The effect of galanin on baseline and GHRH-induced growth hormone secretion in obese childrenS Loche, S Pintus, S G Cella, et al.
Endocrinology|January 8, 1998
Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labelingH Ong, N McNicoll, E Escher, et al.
Pageof 2